Comparisons of Fifth-, Sixth-, and Seventh-Generation Continuous Glucose Monitoring Systems.

John B WelshSimon PsavkoXiaohe ZhangPeggy GaoAndrew K Balo

Published in: Journal of diabetes science and technology (2022)

Adjusted MARD and %20/20 agreement rates were 9.0%/93.1% (abdomen-placed G5), 9.9%/92.3% (abdomen-placed G6), 9.1%/93.2% (abdomen-placed G7), and 8.2%/95.3% (arm-placed G7). Task analysis favored G7 over earlier systems. Favorable clinical outcomes such as hemoglobin A1c reduction and hypoglycemia avoidance seen with G5 and G6 are anticipated with G7 use.

Keyphrases

type diabetes
metabolic syndrome
adipose tissue
red blood cell
insulin resistance